tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market
EDIT
Editas Medicine
RESEARCH TOOLSreports
Want to see EDIT full AI Analyst Report?

Editas Medicine (EDIT) Stock News & Sentiment

3,564 Followers
Editas Medicine Raises Capital Through Public Equity Offering
Premium
Company Announcements
Editas Medicine Raises Capital Through Public Equity Offering
4d ago
8K
EDIT
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
Premium
Company Announcements
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
4d ago
8K
EDIT
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
Premium
Company Announcements
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
4d ago
8K
EDIT
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
Premium
Ratings
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
4d ago
EDIT
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
Premium
Company Announcements
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
16d ago
8K
EDIT
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
Premium
Ratings
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
25d ago
EDIT
EDIT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
EDIT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
26d ago
EDIT
More EDIT News >

EDIT News on the Web

Top Biotech Gainers: QTTB Has A Good Hair Day, GH Wins ACS Recommendation, Ebola Lifts SNGX, NNVX
rttnews
Bullish
Editas Medicine’s $319.4M Offering Signals Major Cash Infusion—and Sets Critical Clinical Milestones
Market Chameleon
Neutral
TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’
TipRanks News
Bullish
Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI
TipRanks News
Bullish
Editas Medicine Raises Capital Through Public Equity Offering
TipRanks News
Neutral
Editas Medicine 55.6M share Secondary priced at $2.25
TipRanks News
Neutral
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
TipRanks News
Neutral
Editas Medicine (EDIT) Shares Drop Following Stock Offering Announcement
GuruFocus News
Bearish

News Score - Last 7 Days

Very Positive
EDIT
Sector Average
Media Buzz
This Week12 articles
Weekly Average2.5 articles
News Sentiment
This Week83%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EDIT’s Media Buzz Sentiment?
12 articles about EDIT were published this week. In an average week, 2.5 articles are published.
    What is EDIT’s weekly average amount of articles?
    In an average week, 2.5 articles about EDIT are published.
      What is EDIT’s News Sentiment?
      83% of articles about EDIT were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        AKTXAkari Therapeutics
        IMMXImmix Biopharma
        SYSo-Young International
        ADOAnteoTech Ltd
        FSPKFFisher & Paykel Healthcare Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week